Searched for
CLARIS LIFESCIENCES IPO
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaitingThe consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris gets Russian nod for anti-infective drugsClaris raised Rs 300 crore in December through its maiden IPO. On Thursday, its stock dipped 2.48% to close at Rs 161.40.
- JM Financial Q3 net up 64.45 pc at Rs 59.50-croreIntegrated financial services provider, JM Financial, today reported a 64.45 per cent increase in its net profit at Rs 59.50-crore for the ...
- JM Financial Q3 net up 64.45 pc at Rs 59.50-croreIntegrated financial services provider, JM Financial, today reported a 64.45 per cent increase in its net profit at Rs 59.50-crore for the ...
- Claris Lifesciences listing: Weak debut, down 1.57 pc on BSEClaris Lifesciences made a subdued debut today, with its shares listing at a discount of 1.57 per cent against the issue price of Rs 228.
- Claris Lifesciences down 8 pc on BSEDrug firm Claris Lifesciences listed at 224.4 rupees on the BSE on Monday, down 1.57 percent from its issue price of 228 rupees a share.
- Claris Life's IPO scrapes through, is bid 1.5 timesThe institutional category was subscribed 1.3 times, while the high-net worth individual category was subscribed 2.03 times. The retail por...
- Claris Lifesciences IPO subscribed 1.5 times on final dayClaris Lifesciences' IPO offer got 1.50 times over-subscribed on the final day of issue on Thursday, thereby generating Rs 379 crore from t...
- Claris IPO hit by withdrawalsDespite a drastic cut in the price band, investors are withdrawing applications in the Claris Lifesciences IPO.
- Claris Life cuts IPO price 20%, extends closing date by 3 daysThe Rs 300-crore initial public offer of Claris Lifesciences became the first casualty of the ongoing investigation on Money Matters scam.
- Claris Lifesciences reduces IPO band, extends closing dateClaris Lifesciences lowered the price band to Rs 228-235 per share due to the poor response from investors, while extending the closing dat...
- Claris Lifesciences IPO: What experts recommendDrugmaker Claris Lifesciences has set a price band of Rs 278-293 a share for its IPO. The offer opened on Wednesday and closes on Friday.
- Subscribe to Claris Lifesciences IPO: KR ChokseyKR Choksey has recommended investors to ‘Subscribe’ to the initial public offering of Claris Lifesciences.
- Subscribe to Claris Lifesciences IPO: Angel BrokingClaris has grown at strong pace with net sales increasing at CAGR of 26.9% & net profit of 65.6%.
- Subscribe to Claris Lifesciences IPO: Nirmal BangThe company has entered primary markets by offering shares in price band of Rs 278-293.
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- Pfizer recalls drug from USPFIZER has recalled a drug made by an Indian partner from the US market while another local partner of the world’s largest drugmaker receiv...
- Carlyle likely to dilute stake in Claris LifeTop private equity firm Carlyle Group is likely to partially exit Claris Lifesciences Ltd, the Rs 800-crore Ahmedabad based parenteral drug...
- Pfizer ties up with Claris for injectablesWorld No 1 pharma company Pfizer on Wednesday announced a marketing tie-up with Rs 800-crore Ahmedabad-based Claris Lifesciences, that spec...
Load More- JM Financial Q3 net up 64.45 pc at Rs 59.50-crore
